Ontology highlight
ABSTRACT: Background
Mineralocorticoid receptor antagonists (MRAs) are disease-modifying agents indicated for heart failure (HF) that can augment diuresis and treat hypokalemia but are underutilized. Prescribing MRAs instead of potassium supplements to treat hypokalemia in the setting of HF could increase the use of MRAs. A best practice alert (BPA) in the electronic medical record that suggests ordering an MRA instead of potassium supplementation for a HF patient with hypokalemia could facilitate this.Objectives
This study sought to examine perspectives of primary care physicians on MRA utilization and BPA usefulness and to develop a novel conceptual model for guiding future BPA development.Methods
We conducted one-on-one semistructured interviews with primary care physician
SUBMITTER: Zhang DT
PROVIDER: S-EPMC11994041 | biostudies-literature | 2025 Mar
REPOSITORIES: biostudies-literature